22 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24831826	59	Small molecule inhibitors targeting activator protein 1 (AP-1).	University of Texas Medical Branch
24491635	4	Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity.	National Defense Medical Center, Taiwan
10937715	45	Novel inhibitors of AP-1 and NF-kappaB mediated gene expression: structure-activity relationship studies of ethyl 4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)++ +pyrimidi ne-5-carboxylate.	Signal Pharmaceuticals
19199792	3	Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.	National Cancer Institute-Frederick
18077363	314	A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.	University of Oxford
21806011	2	Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula.	National Cancer Institute-Frederick
21733691	2	Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii.	Nci-Frederick
21458276	82	Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.	Sanford-Burnham Medical Research Institute
21306129	2	Inhibitors of the oncogenic transcription factor AP-1 from Podocarpus latifolius.	National Cancer Institute-Frederick
21316221	62	Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.	The Scripps Research Institute
20557982	7	Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-kappaB, AP-1 mediated transcription and eIF-4E mediated translational activation: inhibitors of multi-pathways involve in cancer.	B.V. Patel Pharmaceutical Education and Research Development Centre
17982447	1	Surveying polypeptide and protein domain conformation and association with FlAsH and ReAsH.	Yale University
20335039	1	Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents.	B.V. Patel Pharmaceutical Education and Research Development Centre
19064304	4	Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kappaB and AP-1 mediated transcription activation and as potential anti-inflammatory agents.	B.V. Patel Pharmaceutical Education and Research Development Centre
17531481	10	Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.	Yale University
17459703	111	Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.	Ucb Pharma
17055723	17	Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: implication for targeting protein kinases in metabolic diseases.	Abbott Laboratories
16392794	13	Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model.	Toyama Chemical
15293995	17	Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA.	Toyama Chemical
11052805	24	Inhibitors of NF-kappaB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3', 5'-bis(trifluoromethyl)phenyl)carboxamide].	Signal Pharmaceuticals
30525604	1	Melonoside B and Melonosins A and B, Lipids Containing Multifunctionalized ?-Hydroxy Fatty Acid Amides from the Far Eastern Marine Sponge Melonanchora kobjakovae.	Far Eastern Branch of The Russian Academy of Sciences